Depo Medrol

In some countries, this medicine may only be approved for veterinary use.

In the US, Depo-Medrol (methylprednisolone systemic) is a member of the drug class glucocorticoids and is used to treat Adrenogenital Syndrome, Asthma, Asthma - acute, Asthma - Maintenance, Dermatologic Lesion, Gout - Acute, Hay Fever, Immunosuppression, Inflammatory Conditions, Neuralgia, Osteoarthritis, Rheumatoid Arthritis and Shock.

US matches:

• Depo-Medrol Suspension


• Depo-Medrol

Ingredient matches for Depo-Medrol

Methylprednisolone

Methylprednisolone 21-acetate (a derivative of Methylprednisolone) is reported as an ingredient of Depo-Medrol in the following countries:

• Australia


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Bulgaria


• Canada


• Chile


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Ecuador


• Estonia


• Ethiopia


• Finland


• France


• Georgia


• Ghana


• Greece


• Hong Kong


• Hungary


• Iceland


• India


• Indonesia


• Israel


• Italy


• Japan


• Kenya


• Latvia


• Liberia


• Luxembourg


• Malaysia


• Mexico


• Myanmar


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Poland


• Portugal


• Romania


• Sierra Leone


• Slovakia


• Slovenia


• South Africa


• Sweden


• Switzerland


• Tanzania


• Thailand


• Turkey


• Uganda


• United States


• Vietnam


• Zimbabwe

International Drug Name Search